Active and Passive Immunotherapy Against Ebola Virus

1. Background of Ebola and EHF (00:34)

2. Animal models and pathogenicity (14:43)

3. Vaccine development (30:32)

-Replication-defective ADV vector (32:27)

-Replicating VSV vector (38:56)

4. Vaccine in post exposure treatment (1:03:35)

5. Passive immunization (1:20:43)

Conference by Thomas Geisbert 6 February 2009; Coordinators of the courses: B. Horvat V. Volchkov;
Filmed by chezmoiprod; Multimedia by N Alazard-Dany, T Mahlakoiv, G Vidal with the support of UNISCIEL;

Copyright ENS Lyon; Master Biosciences Virus and Immunity 2009 session was sponsored by Sanofi Pasteur.